Literature DB >> 1761183

Effect of bradykinin antagonists, NG-monomethyl-L-arginine and L-NG-nitro arginine on phospholipase A2 induced oedema in rat paw.

G Cirino1, C Cicala, L Sorrentino, D Regoli.   

Abstract

1. The rat paw oedema produced by a local injection of phospholipase A2 from Naja mocambique mocambique has been shown to be mainly driven by the liberation of serotonin and kinins. 2. Using specific bradykinin receptor antagonists we have shown that kinins are acting through B2 receptors. 3. Using endothelium-derived relaxing factor (EDRF) synthesis inhibitors NG-monomethyl-L-arginine and L-NG-nitro arginine we have tested the possible envolvement of EDRF as mediator. 4. Our work supports the view that extracellular phospholipases A2 are involved in inflammation, and suggests a role for EDRF as mediator of extravasation in this model of inflammation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1761183     DOI: 10.1016/0306-3623(91)90209-o

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  3 in total

1.  Involvement of endogenous nitric oxide in the mechanism of bradykinin-induced peripheral hyperalgesia.

Authors:  A Nakamura; M Fujita; H Shiomi
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

2.  Anti-inflammatory and analgesic activity of the bradykinin antagonist, icatibant (Hoe 140), against an extract from Porphyromonas gingivalis.

Authors:  T Griesbacher; R L Sutliff; F Lembeck
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

Review 3.  Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy.

Authors:  Alexandru A Sabo; Maria Dudau; George L Constantin; Tudor C Pop; Christoph-M Geilfus; Alessio Naccarati; Mihnea P Dragomir
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.